Mirum Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) on January 14, 2020, covering events occurring on January 10, 2020. The filing primarily addresses the finalization of 2019 executive compensation and a key management appointment.
Key Financial Metrics
The filing does not provide company-wide revenue, profit, cash flow, or debt metrics. It focuses exclusively on executive compensation adjustments for the 2019 fiscal year. The revised total compensation for named executive officers (NEOs) for 2019 is as follows:
- Michael Grey (Former Executive Chairman/CEO): $5,662,396 (Includes $150,000 bonus and $5,212,396 in option awards).
- Christopher Peetz (CEO/President): $6,235,185 (Includes $286,100 bonus and $5,491,471 in option awards).
- Pamela Vig, Ph.D. (CSO): $2,681,958 (Includes $155,300 bonus and $2,171,832 in option awards).
- Lara Longpre (CDO): $2,681,958 (Includes $155,300 bonus and $2,171,832 in option awards).
Note: Option award values represent grant date fair value per FASB ASC Topic 718 and do not reflect actual cash received.
Material Changes
The primary material change is the revision of the Summary Compensation Table previously disclosed in the Company's January 8, 2020 Prospectus. The prior filing omitted 2019 bonuses for NEOs as they were undetermined at that time. This 8-K incorporates the approved bonuses awarded on January 10, 2020.
Management Commentary and Corporate Events
- Executive Promotion: Ian Clements, Ph.D., was promoted from Senior Vice President of Finance and Communications to Chief Financial Officer (CFO), effective January 10, 2020.
- Compensation Approval: The Compensation Committee approved 2019 performance bonuses for all named executive officers.
- Management Transition: The filing references a planned management transition involving Michael Grey, noting a new option grant to him on January 1, 2020, which is excluded from the 2019 compensation table.
Investor Verification Checklist
- Verify the full text of the press release regarding Ian Clements' promotion (Exhibit 99.1).
- Review the January 8, 2020 Prospectus (File No. 333-235825) to compare the original compensation table against these revised figures.
- Confirm the terms of the January 1, 2020 option grant to Michael Grey mentioned in footnote (1).
- Assess the impact of the new CFO appointment on the company's financial reporting and strategic direction.